Articles On Bioxyne (ASX:BXN)

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

ASX 200 closes about 0.5% higher after a half-decent lead in from Wall Street Material and Discretionary offset losses in Healthcare and IT  Small cap winners led by EML payments, GCX Metals   It was exciting stuff on Australian share ma...

Stockhead’s In-Case-You-Missed-It highlights some strongest performing ASX stocks that might have slipped your notice today.  It’s a short, sharp update to help frame the trading day by showing some of the biggest movers in percentage terms...

Stockhead’s Top 10 at 11, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

 The ASX 200 benchmark has climbed down from highs at lunch to finish on +0.39%. Health Care was well out in front of the market all day, thanks to a chunky bump for CSL. Voltaic Strategic Resources won the Small Caps Cup, rising 22.5% for...

Bioxyne subsidiary Breathe Life Sciences has joined forces with CanXChange to facilitate wholesale trading in Australia’s growing cannabis market. Bioxyne’s (ASX:BXN) wholly-owned subsidiary Breathe Life Sciences (BLS) and tech company Can...

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

The ASX closed down 0.58 per cent. All sectors except communications traded down. Helping to boost consumer staples stocks was healthy and beauty products company Bioxyne – up 20 per cent. While Aussie Broadband helped to lift comm...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

What a time to be alive. As the clock struck midnight to herald the start of the 23/24 financial year, Australia’s ability to legally prescribe through qualified medical practitioners MDMA (ecstasy) and psilocybin – the active ingredient in...

The ASX 200 built a platform for success today. Which failed. It fell flat at close Sectors wise, Financials, IT and Industrials did okay. The others, very much including Health Care and Utilities, didn’t Notable performers today: Nuix (AS...

ASX extended its losses for a second day running, ending 0.20% in the red Real Estate, Telcos, Industrials and Energy stonks led the losers, while Financials and Health Care get the teacher’s smiley stamps today The day’s clear winner was...

ASX chopped about sideways, losing any slight semblance of  fizz at close: -0.063% IT, Discretionary and Industrials led sectors, while Materials lagged The day’s clear winner was Mantle Minerals, up 50% at day’s end on further exploration...

Stock Insiders is a podcast series focussed on investing, hosted by TV presenter and news journalist Christina Morrissy.  In this episode Christina chats to Sam Watson, co-CEO at Bioxyne Limited (ASX:BXN). Bioxyne recently announced it hit...

The ASX200 closed up 0.38 per cent today. Energy and materials stocks were the strongest performers, while healthcare, tech stocks, comms, consumer staples and utilities lost ground. The Reserve Bank’s Governor Philip Lowe said he wo...

ASX  gains 0.46% while the emerging companies index falls RBA board will meet eight times instead of 11 times annually to set interest rates Nickel Search again intersects massive sulphide mineralisation at the Sexton prospect   After e...

ASX snaps a 4-day run of bruising luck with a welcome 1.5% gain Techies did a lot of the heavy lifting, while the Goldies put on a +3.54% show The day’s clear winner was Mobilicom, up 150% at day’s end on juicy defence news   Local market...

The ASX 200 is down nearly 0.5 per cent at market close, declining throughout the day after a strong start.  Information Technology was the only sector to hold up in the green, with Vista Group, Echo IQ, Bigtincan Holdings, Orcoda, ArchT...

ASX dips 0.56% despite a solid kickstart first thing this morning InfoTech outperforms the market again, leading on +0.21% for the day Heavy Minerals banks a 90% bump on some big time garnet news   For 10 fantastic minutes this morning, l...

Bioxyne’s acquisition of Breathe Life Sciences is paying off with its well-established Dr Watson® brand of cannabis products continuing to be a consumer favourite. Healthcare company Bioxyne (ASX:BXN) has announced it hit a $1 million annu...

ASX 200 benchmark climbs 0.65% despite a sour lead-in from Wall Street and Europe. Real Estate sector banks solid wins after shopping centres put on a big day.  Forrestania Resources hits 162% on thick pegmatite news, but the ASX has asked...

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Bioxyne’s acquisition of Breathe Life Sciences (BLS) gives it a new, readymade consumer-facing pathway, positioning the company for strong growth both in Australia and globally.  Healthcare company Bioxyne (ASX:BXN) said it has entered int...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Biotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We take a look at the ASX biotech winners in May   There are clear signs the biotech sector is springing back to life after a disappointing 2...

The ASX continued its tragic decline, falling 1.05% over the course of a rubbish day InfoTech took trend-bucking to a whole new level, outperforming the market by 3.5% Something’s up at IncentiaPay, because it’s climbed 71.4% on absolutely...

Pfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of these weight loss drugs? Best and worst performing ASX biotechs over the past week   Earlier this week, Pfizer surprised the market by say...

The ASX fell this morning and – sadly – just never recovered. It’s down 0.64%. Aside from Happy Times among the lithium players, it’s been a total snoozefest Rubix Resources (ASX:RB6) takes bragging rights with a 41.6% hike for the day  ...

The Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health and Telehealth also received significant funding allocations Here are the ASX stocks that could benefit   Medicare, telehealth and mental...

‘More of the same’ since lunchtime saw the benchmark land at -0.25% for the day Health Care coughed up a 1.09% lift while Financials weighed heavily on -0.71% Magnum Mining wins the Small Caps trophy with +44.1% thanks to Mitsubishi deal...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Good news is bad news for the US economy Aussie benchmark goes deep into a pre-Christmas shame spiral Ho ho oh s%#$! What just happened?   The Closing Jingle Bell has rung, so that’s it until after Christmas for 2022! What a pity today’s...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 down 0.75%, dropping for the third straight day Small cap index falls 0.0.56% and 7 out 11 sectors finish lower China could reopen next year with ‘seismic’ implications for the rest of the world   The local bourse has dropped for...

ASX 200 edges higher,  small cap index falls 0.44% 7 out of 11 sectors were in the green with Tech up 1.25% Downbeat RBA Governor speech highlights all the things that could go wrong with the economy   Last night the leads were decent, th...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

ASX 200 ends about 0.066% lower Small cap index fights way back, scrapes home with a brave win MSL, VG1 bring home bacon Tuesday is a tale of two indices… One, a tough little fighter: VIa marketindex.comThe other, uncertain, lacking confi...

Small caps drops 0.53%, fails to recover from the RBA speech overnight CBA says history shows stocks tend to advance after US midterms US megacap and tech companies had a bit of a rough earnings season   Small caps closed 0.53% lower toda...

Wall St surged after a media report signalled the Fed might be slowing down its rate hikes from December Snap Inc plunged 28% on a bad quarter Tuesday’s Federal Budget will be the market’s focus this week Local shares are set to open shar...

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

Benchmark rises early, wobbles late, gains 0.4% Small caps all over the shop today, up 0.9% Metals Grove jumps over 50%    Local markets have climbed the mountain of conflict today: (NB: explicit language).   The ASX 200 index was initia...

Benchmark set to end the day down 1.5% Small caps smashed down 4.2% Greenwing up 70% on Chinese investment   Look. No-one likes Monday’s except possibly the last four or five Prime Ministers. I definitely sense S Morrison and K Rudd and c...